| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029202 |
| Receipt No. | R000033136 |
| Official scientific title of the study | Study on effects of functional fermented tea leaf powder, MarugotoHakkocha, made from green tea leaves and loquat leaves on postprandial blood glucose levels |
| Date of disclosure of the study information | 2017/09/20 |
| Last modified on | 2018/03/22 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study on effects of functional fermented tea leaf powder, MarugotoHakkocha, made from green tea leaves and loquat leaves on postprandial blood glucose levels | |
| Title of the study (Brief title) | Effects of fermented tea leaf powder on postprandial blood glucose levels | |
| Region |
|
|
| Condition | ||
| Condition | Postprandial huperglycemia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of a fermented tea leaf powder on postprandial hyperglycemia |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Postprandial blood glucose level,Blood insulin concentration |
| Key secondary outcomes | Body weight,Blood pressure,Serum LDL-cholesterol,Serum HDL-cholesterol,Serum triglyceride,White blood cell count,Red blood cell count,Hemoglobin,Hematocrit,Platelet count,Total protein,Albumin,GOT,GPT,LDH,Total bilirubin,ALP,Gamma GTP,Urea nitrogen,Creatinine,Uric acid,HbA1c,Urinary sugar, Urinary protein |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects ingested a single intake of the active meal, and injested a single intake of the placebo meal after 7 days or 14 days. | |
| Interventions/Control_2 | The subjects ingested a single intake of the active meal, and injested a single intake of the placebo meal after 7 days or 14 days. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy male and female between 20 and 70 years old
2) Those who are liable to rise in postprandial blood glucose levels during screening tests 3) Individuals who can refrain from drinking and eating during the test period 4) Individuals who understand the purpose and contents of the experiment |
|||
| Key exclusion criteria | 1)Individuals taking drugs, supplements and healthy foods which affect the blood glucose levels
2)Those who can not stop taking supplements or health foods that may affect blood glucose levels during the test period 3)Subjects who are contracting kidney and/or liver diseases 4)Those who have been diagnosed with diabetes 5)Individuals with a chronic diseases 6)Person who donated more than 400 ml of blood within 3 months prior to the study 7)Those who can not stop taking a large amount of green tea or black tea during the test period 8)Pregnant women, or women with intending to become pregnant, and lactating woman 9)Individuals participating or intending to participate in a drug administration test 10)Individuals judged by the doctor to be unsuitable |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunari Tanaka |
| Organization | Univercity of Nagasaki |
| Division name | Faculty of Nursing and Nutrition |
| Address | 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195 |
| TEL | 095-813-5216 |
| katanaka@sun.ac.jp | |
| Public contact | |
| Name of contact person | Hideki Ito |
| Organization | Univercity of Nagasaki |
| Division name | Regional Partnership Center |
| Address | 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195 |
| TEL | 095-813-5500 |
| Homepage URL | |
| katanaka@sun.ac.jp | |
| Sponsor | |
| Institute | Univercity of Nagasaki |
| Institute | |
| Department | |
| Funding Source | |
| Organization | charle Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033136 |